Dr. Brian I. Rini
Claim this profileVanderbilt University/Ingram Cancer Center
Studies Thyroid Cancer
Studies Renal Cell Carcinoma
9 reported clinical trials
15 drugs studied
Area of expertise
1Thyroid Cancer
Stage IV
Stage III
SETD2 positive
2Renal Cell Carcinoma
Stage IV
Stage III
SETD2 positive
Affiliated Hospitals
Clinical Trials Brian I. Rini is currently running
SRF388 + Pembrolizumab
for Cancer
This trial tests CHS-388, a protein that blocks IL-27, in patients with severe cancers like kidney, liver, and lung cancer. The goal is to see if it helps the immune system fight cancer better.
Recruiting1 award Phase 134 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
More about Brian I. Rini
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Brian I. Rini has experience with
- Ipilimumab
- Nivolumab
- Cabozantinib
- Anti-OX40 Antibody PF-04518600
- Axitinib
- Pembrolizumab
Breakdown of trials Brian I. Rini has run
Thyroid Cancer
Renal Cell Carcinoma
Kidney Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian I. Rini specialize in?
Brian I. Rini focuses on Thyroid Cancer and Renal Cell Carcinoma. In particular, much of their work with Thyroid Cancer has involved Stage IV patients, or patients who are Stage III.
Is Brian I. Rini currently recruiting for clinical trials?
Yes, Brian I. Rini is currently recruiting for 3 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Brian I. Rini has studied deeply?
Yes, Brian I. Rini has studied treatments such as Ipilimumab, Nivolumab, Cabozantinib.
What is the best way to schedule an appointment with Brian I. Rini?
Apply for one of the trials that Brian I. Rini is conducting.
What is the office address of Brian I. Rini?
The office of Brian I. Rini is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.